title: Individualizing the intravitreal anti-VEGF dosing regimen for long-term management of neovascular AMD.
authors.forename: K Bailey
authors.initials: KB
authors.lastname: Freund
authors.forename: Michael
authors.initials: M
authors.lastname: Engelbert
authors.forename: Howard F
authors.initials: HF
authors.lastname: Fine
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D057285:Precision Medicine; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014792:Visual Acuity / Q000502:physiology; D057135:Wet Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A